Literature DB >> 16889544

Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation.

S Saab1, A Shpaner, Y Zhao, I Brito, F Durazo, S Han, D G Farmer, R M Ghobrial, H Yersiz, L I Goldstein, M J Tong, R W Busuttil.   

Abstract

The prevalence and risk factors for diabetes mellitus after liver transplantation are not well understood. Thus, we sought to identify independent risk factors for the development of diabetes after liver transplantation using currently accepted medical criteria. We studied the prevalence and risk factors in 253 adult recipients transplanted at UCLA between January 1998 and December 2002. Analysis of the retrospective data was performed using demographic, immunosuppression and liver disease variables. Factors found to be significant on a univariate analysis were further studied in a multivariate analysis. There were 158 men and 95 women in our study. The mean age was 51.4 +/- 11.0 years. The mean [+/- standard deviation (SD) pretransplant body mass index was 26.7 (+/-5.1). Most patients were transplanted for hepatitis C (HCV). The prevalence of diabetes after transplantation was 17.8%. In a multivariate analysis only gender [odds ratio (OR) = 0.37; p = 0.02] was independently predictive of the development of diabetes. This study in a large liver transplant recipient population identifies male gender as an independent risk factor for the development of diabetes. Follow-up studies are needed to assess the impact of diabetes, and its intervention on post-transplant morbidity and mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16889544     DOI: 10.1111/j.1600-6143.2006.01385.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

Review 1.  Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis.

Authors:  Da-Wei Li; Tian-Fei Lu; Xiang-Wei Hua; Hui-Juan Dai; Xiao-Lan Cui; Jian-Jian Zhang; Qiang Xia
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

2.  Medical Management of Metabolic Complications of Liver Transplant Recipients.

Authors:  Abbey Barnard; Peter Konyn; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-10

Review 3.  Hepatitis C virus and type 2 diabetes.

Authors:  Francesco Negro; Mahnaz Alaei
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

4.  Metabolic syndrome after liver transplantation: preventable illness or common consequence?

Authors:  Eric R Kallwitz
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

Review 5.  Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities.

Authors:  Mina Shaker; Adam Tabbaa; Mazen Albeldawi; Naim Alkhouri
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

6.  Endocrine Disorders in Pediatric and Adolescent Liver-transplant Recipients.

Authors:  H Ilkhanipoor; M Ahangar Davoodi; S M Dehghani; H Karamifar; S M Abdollahzadeh
Journal:  Int J Organ Transplant Med       Date:  2019

7.  Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation.

Authors:  Elizabeth J Carey; Bashar A Aqel; Thomas J Byrne; David D Douglas; Jorge Rakela; Hugo E Vargas; Adyr A Moss; David C Mulligan; K Sudhakar Reddy; Harini A Chakkera
Journal:  J Transplant       Date:  2012-01-29

8.  New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database.

Authors:  Anitha D Yadav; Yu-Hui Chang; Bashar A Aqel; Thomas J Byrne; Harini A Chakkera; David D Douglas; David C Mulligan; Jorge Rakela; Hugo E Vargas; Elizabeth J Carey
Journal:  J Transplant       Date:  2013-09-24

Review 9.  Medical management of metabolic and cardiovascular complications after liver transplantation.

Authors:  Chiara Becchetti; Melisa Dirchwolf; Vanessa Banz; Jean-François Dufour
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

Review 10.  New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy.

Authors:  Ali R Chaitou; Surbhi Valmiki; Mrinaal Valmiki; Maria Zahid; Mohamed A Aid; Peter Fawzy; Safeera Khan
Journal:  Cureus       Date:  2022-03-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.